Impact of -related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders.
作者信息
Kountouras Jannis, Papaefthymiou Apostolis, Polyzos Stergios A, Vardaka Elisabeth, Boziki Marina, Kyriakopoulos Anthony, Sampsonas Fotios, Agrotis George, Karafyllidou Kyriaki, Doulberis Michael
机构信息
Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Macedonia, Greece.
Department of Gastroenterology, University Hospital of Larisa, Mezourlo, Larisa, Greece.
出版信息
J Neurogastroenterol Motil. 2021 Oct 30;27(4):653-654. doi: 10.5056/jnm21059.
Abstract
摘要
相似文献
1
Impact of -related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders.
J Neurogastroenterol Motil. 2021 Oct 30;27(4):653-654. doi: 10.5056/jnm21059.
2
Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders.
J Neurogastroenterol Motil. 2021 Jan 30;27(1):19-34. doi: 10.5056/jnm20149.
3
Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis.
Metabolism. 2018 Oct;87:18-24. doi: 10.1016/j.metabol.2018.06.008. Epub 2018 Jun 21.
4
The Emerging Role of Helicobacter Pylori-Induced Metabolic Gastrointestinal Dysmotility and Neurodegeneration.
Curr Mol Med. 2017;17(6):389-404. doi: 10.2174/1566524018666171219094837.
5
Effect of on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer.
Gut. 2020 Sep;69(9):1598-1607. doi: 10.1136/gutjnl-2019-319696. Epub 2019 Dec 19.
6
Helicobacter pylori Infection, the Gastric Microbiome and Gastric Cancer.
Adv Exp Med Biol. 2019;1149:195-210. doi: 10.1007/5584_2019_366.
7
Helicobacter pylori infection and gastric emptying of indigestible solids in patients with dysmotility-like dyspepsia.
Scand J Gastroenterol. 1997 Jul;32(7):676-80. doi: 10.3109/00365529708996517.
8
Infection Aggravates Dysbiosis of Gut Microbiome in Children With Gastritis.
Front Cell Infect Microbiol. 2019 Nov 7;9:375. doi: 10.3389/fcimb.2019.00375. eCollection 2019.
9
Imbalance of Gastrointestinal Microbiota in the Pathogenesis of Helicobacter pylori-Associated Diseases.
Helicobacter. 2016 Oct;21(5):337-48. doi: 10.1111/hel.12297. Epub 2016 Feb 15.
10
Intestinal nerve cell injury occurs prior to insulin resistance in female mice ingesting a high-fat diet.
Cell Tissue Res. 2019 Jun;376(3):325-340. doi: 10.1007/s00441-019-03002-0. Epub 2019 Feb 18.
本文引用的文献
1
Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders.
J Neurogastroenterol Motil. 2021 Jan 30;27(1):19-34. doi: 10.5056/jnm20149.
2
Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.
Medicina (Kaunas). 2020 Jul 8;56(7):339. doi: 10.3390/medicina56070339.
3
Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease.
J Gastrointestin Liver Dis. 2016 Jun;25(2):159-65. doi: 10.15403/jgld.2014.1121.252.iwg.
4
Potential impact of Helicobacter pylori-related human β-defensin-1 on hepatic encephalopathy and neurodegeneration.
Ann Gastroenterol. 2016 Jan-Mar;29(1):99.
5
Extragastric Diseases and Helicobacter pylori.
Helicobacter. 2015 Sep;20 Suppl 1:40-6. doi: 10.1111/hel.12256.
6
A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders.
Med Hypotheses. 2014 Mar;82(3):368-73. doi: 10.1016/j.mehy.2013.12.025. Epub 2014 Jan 14.
7
Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis?
Rheumatol Int. 2013 Nov;33(11):2943-8. doi: 10.1007/s00296-012-2585-z. Epub 2012 Dec 6.
8
Role of diabetes mellitus on hepatic encephalopathy.
Metab Brain Dis. 2013 Jun;28(2):277-9. doi: 10.1007/s11011-012-9354-2. Epub 2012 Nov 24.
9
Helicobacter pylori may be a common denominator associated with systemic and multiple sclerosis.
Joint Bone Spine. 2011 Mar;78(2):222-3; author reply 223. doi: 10.1016/j.jbspin.2011.01.006. Epub 2011 Feb 22.
10
The impact of B(12) treatment on gastric emptying time in patients with Helicobacter pylori infection.
J Clin Gastroenterol. 2003 Sep;37(3):230-3. doi: 10.1097/00004836-200309000-00008.
Zotero 插件